Douglas S. Hawkins, MD, is Associate Hematology/Oncology Division Chief, Associate Director of the Center for Clinical and Translational Research at Seattle Childrens Hospital (SCH), clinician at SCH, and Professor of Pediatrics at the University of Washington School of Medicine. Dr. Hawkins is the principal investigator for COG activity at SCH and Chair of the Children's Oncology Group (COG) Soft Tissue Sarcoma Committee.

Dr. Hawkins is a leader in the Children's Oncology Group (COG). He is the Chair of the Soft Tissue Sarcoma Committee, which oversees the conduct of biology studies and clinical trials for rhabdomyosarcoma and other soft tissue sarcomas across North America. He is a member of the COG Bone Tumor Steering Committee. He is also the Chair of the COG Scientific and Discipline Chairs Committee. Dr. Hawkins has focused on clinical research, particularly in the treatment of pediatric sarcomas. He has been the chair of two COG clinical trials, one for Ewing sarcoma and another for rhabdomyosarcoma. He chairs the international EURO EWING Consortium External Advisory Board.